Shares of AirSculpt Technologies (NASDAQ: AIRS) were in freefall in pre-market trading on Friday after the provider of body contouring procedures reported disappointing Q3 earnings.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The company reported revenues of $38.9 million in Q3, up 12.2% year-over-year but still missed estimates by $5.1 million. AirSculpt’s loss came in at $0.13 per share while analysts were expecting a profit of $0.02.
For FY22, AIRS also reduced its revenue outlook and now expects it to be between $168 million and 170 million and lowered Adjusted EBITDA outlook to range from $45 million to $47 million.